0001144204-17-012518.txt : 20170302
0001144204-17-012518.hdr.sgml : 20170302
20170302163031
ACCESSION NUMBER: 0001144204-17-012518
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170228
FILED AS OF DATE: 20170302
DATE AS OF CHANGE: 20170302
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: China Biologic Products, Inc.
CENTRAL INDEX KEY: 0001369868
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 752308816
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 18TH FL, JIALONG INTERNATIONALBUILDING
STREET 2: 19 CHAOYANG PARK ROAD, CHAOYANG DISTRICT
CITY: BEIJING
STATE: F4
ZIP: 100125
BUSINESS PHONE: 86-10-6598-3111
MAIL ADDRESS:
STREET 1: 18TH FL, JIALONG INTERNATIONALBUILDING
STREET 2: 19 CHAOYANG PARK ROAD, CHAOYANG DISTRICT
CITY: BEIJING
STATE: F4
ZIP: 100125
FORMER COMPANY:
FORMER CONFORMED NAME: GRC Holdings, Inc.
DATE OF NAME CHANGE: 20060721
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gao David
CENTRAL INDEX KEY: 0001331795
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34566
FILM NUMBER: 17659278
MAIL ADDRESS:
STREET 1: C/ BEIJING MED-PHARM CORPORATION
STREET 2: 600 W. GERMANTOWN PIKE, SUITE 400
CITY: PLYMOUTH MEETING
STATE: PA
ZIP: 19462
4
1
v460976_4.xml
OWNERSHIP DOCUMENT
X0306
4
2017-02-28
0
0001369868
China Biologic Products, Inc.
CBPO
0001331795
Gao David
18TH FLOOR, JIALONG INTERNATIONAL
BUILDING, 19 CHAOYANG PARK ROAD
BEIJING
F4
100125
CHINA
1
1
0
0
Chief Executive Officer
Common Stock
2017-02-28
4
S
0
62604
100.69
D
449396
D
Common Stock
2017-03-01
4
S
0
54049
100.57
D
395347
D
Represents 62,604 shares of common stock sold in the open market at a weighted average price of $100.69 per share on Februray 28, 2017. The Reporting Person intends to use the proceeds from the sale to pay income tax due in connection with the scheduled vesting of certain restricted stock held by the Reporting Person and the exercise of certain stock options held by the Reporting Person.
Represents 54,049 shares of common stock sold in the open market at a weighted average price of $100.57 per share on March 1, 2017. The Reporting Person intends to use the proceeds from the sale to pay income tax due in connection with the scheduled vesting of certain restricted stock held by the Reporting Person and the exercise of certain stock options held by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in the open market at prices ranging from $99.04 to $104.48, inclusive.*
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in the open market at prices ranging from $100.00 to $102.57, inclusive.*
* The Reporting Person undertakes to provide to any security holders of the Issuer or the staff of the Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in Footnotes 2 and 3.
/s/ David (Xiaoying) Gao
2017-03-02